Ipamorelin (RUO) | Highly Selective GH Secretagogue | ≥99% Purity
Product Specifications
- Product Name : Ipamorelin (Research Grade)
- CAS Number : 170851-70-4
- Peptide Sequence : Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Molecular Formula : C38H49N9O5
- Molecular Weight : 711.868 Da
- Purity : 99% or higher (HPLC Verified)
- Form : Lyophilized Crystalline Powder
- Solubility : Soluble in water or sterile saline
- Target Receptor : Ghrelin Receptor (GHS-R1a)
Disclaimer : For Research Use Only (RUO). Not for human use.
Chemical Identity & Characteristics
Ipamorelin (NNC 26-0161) is a synthetic pentapeptide recognized as the first selective agonist of the GHS-R1a receptor. Developed through a rigorous structural-activity relationship (SAR) program, its design specifically excludes the dipeptide Ala-Trp to eliminate the non-selective endocrine activity found in earlier secretagogues.
- Aib ($alpha$-aminoisobutyric acid) : Located at the N-terminus, this non-proteinogenic residue creates a Steric hindrance that induces a helical backbone conformation, protecting the peptide from enzymatic hydrolysis
- D-2-Nal (D-2-naphthylalanine) : This residue features a bulky, bicyclic naphthalene group that acts as a molecular “anchor” in the receptor’s hydrophobic binding pocket, ensuring high-affinity binding (Ki = 2.3 nM)
- D-Isomer Chirality : The use of D-isomers (D-2-Nal and D-Phe) makes the peptide less recognizable to endogenous proteases, extending its functional half-life to approximately 2 hours in humans.
The Selectivity Paradigm
The defining characteristic of Ipamorelin is its “GH-specific” profile. Unlike GHRP-2 or GHRP-6, Ipamorelin does not induce significant surges in:
ACTH & Cortisol : Even at doses 200-fold higher than the effective threshold for GH release
Prolactin : No meaningful elevation observed in clinical models.
Appetite Stimulation : Does not strongly activate the orexigenic (hunger) pathways associated with GHRP-6.
Research Context & Clinical Insights (2024–2025)
Muscle preservation : In a 12-month trial involving subjects aged 65–80, daily administration resulted in a 4.2% increase in lean body mass, compared to a 0.3% increase in the placebo group.
Skeletal Geometry : Research confirms Ipamorelin increases Bone Mineral Content (BMC) by stimulating true geometric growth of cortical bone dimensions.
Neuroprotection (2024) : Recent studies in Neuropharmacology demonstrate reduced neuroinflammation in animal models of traumatic brain injury (TBI) via GHS-R1a pathways.
Metabolic Syndrome : Observations include an 11.3% reduction in visceral adipose tissue and an 18% improvement in insulin sensitivity (HOMA-IR) over 6 months.
Comparative Selectivity Profile: GHS-R1a Agonists
| Parameter | Ipamorelin | GHRP-6 | GHRP-2 |
|---|---|---|---|
| GH Stimulation | High | High | High |
| ACTH/Cortisol Rise | None / Negligible | Moderate | High |
| Prolactin Surge | None / Negligible | Moderate | High |
| Appetite Induction | None / Negligible | High | Moderate |
| Desensitization Risk | Low | Moderate | Moderate |
Chemical identity of Ipamorelin peptide
High-resolution 2D molecular structure diagram of Ipamorelin (NNC 26-0161), depicting its peptide-mimetic framework with multiple amide linkages, aromatic rings, and a nitrogen-containing heterocycle. This visualization is used for research documentation and structure–activity discussions of selective GHS-R1a agonists (RUO).
” data-image-caption=”
2D structural formula of Ipamorelin (NNC 26-0161), a selective GHS-R1a agonist used in research.
” data-large-file=”https://profoundaminos.com/wp-content/uploads/2024/10/Ipamorelin-NNC-26-0161-Chemical-Structure.webp” class=”size-medium wp-image-89297″ src=”https://licensebpeptides.com/wp-content/uploads/2026/06/Ipamorelin-NNC-26-0161-Chemical-Structure-300×300-1.webp” alt=”2D chemical structure of Ipamorelin peptide (NNC 26-0161), showing amide bonds, aromatic rings, and heterocycle in the peptide-like scaffold.” width=”300″ height=”300″ srcset=”https://licensebpeptides.com/wp-content/uploads/2026/06/Ipamorelin-NNC-26-0161-Chemical-Structure-300×300-1.webp 300w, https://profoundaminos.com/wp-content/uploads/2024/10/Ipamorelin-NNC-26-0161-Chemical-Structure-150×150.webp 150w, https://profoundaminos.com/wp-content/uploads/2024/10/Ipamorelin-NNC-26-0161-Chemical-Structure-768×768.webp 768w, https://profoundaminos.com/wp-content/uploads/2024/10/Ipamorelin-NNC-26-0161-Chemical-Structure-700×700.webp 700w, https://profoundaminos.com/wp-content/uploads/2024/10/Ipamorelin-NNC-26-0161-Chemical-Structure-500×500.webp 500w, https://profoundaminos.com/wp-content/uploads/2024/10/Ipamorelin-NNC-26-0161-Chemical-Structure-100×100.webp 100w, https://profoundaminos.com/wp-content/uploads/2024/10/Ipamorelin-NNC-26-0161-Chemical-Structure.webp 1000w” sizes=”auto, (max-width: 300px) 100vw, 300px”>
chemical identity of Ipamorelin peptide (C38H49N9O5) showing the pentapeptide sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 for high-purity laboratory reference and identification.
Why Researchers Source Ipamorelin from Profound Aminos
Profound Aminos provides the analytical transparency required for institutional-grade research.
Lot-Specific Transparency :
Every shipment includes a verified Certificate of Analysis (COA) with HPLC chromatograms and Mass Spectrometry data, confirming purity of 99% or above.
USA-Based Cold-Chain Logistics:
To prevent thermal degradation, all peptides are stored at -20°C and shipped from our USA facility to ensure immediate experimental potency.
Endotoxin Monitoring :
We screen for endotoxins to < 1.0 EU/mg ensure suitability for sensitive in vitro assays and cellular modeling.
Total Traceability :
Every vial is batch-tracked, allowing researchers to maintain strict quality control in longitudinal studies.
Regulatory & Compliance Statement
FDA Status : Ipamorelin is currently on Category 2 of the Interim Policy on Compounding due to its non-natural amino acid content. It is not FDA-approved for human use.
WADA Status : Prohibited at all times as a Growth Hormone Secretagogue
RUO Designation : This compound is provided strictly for Laboratory Research Use Only.
Frequently Asked Questions
Q: Why is Ipamorelin often combined with CJC-1295?
A: GHRH analogs like CJC-1295 (the amplifier) and GHS-R1a agonists like Ipamorelin (the trigger) act synergistically to produce a massive GH release greater than the sum of their individual effects
Q: Does Ipamorelin require a “refractory period”?
A: Yes. Because it triggers a “dump” of stored GH, the pituitary requires a period to resynthesize hormone stores before another pulse can be triggered
Q: How should it be stored for long-term research?
A: Lyophilized powder should be stored at -20°C to -80°C for 12–24 months of stability.




Reviews
There are no reviews yet.